Breaking News
April 19, 2018 - Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer’s
April 19, 2018 - Case study shows how intravascular ultrasound imaging helps detect acute aortic syndrome
April 19, 2018 - Research reveals new mechanism by which HIV evades the immune system
April 19, 2018 - Nanodisc-delivered cancer treatment helps eliminate tumors
April 19, 2018 - Functional connectivity MRI could help detect brain disorders and diseases
April 19, 2018 - Finding better way to quantify neuropathy symptoms and treatment efficacy
April 19, 2018 - Study examines effectiveness of caregiver education about sickle cell trait
April 19, 2018 - High-resolution images of tumor vasculature using new technology
April 19, 2018 - Lack of sleep may be linked to risk factor for Alzheimer’s disease
April 19, 2018 - Study finds neurotransmitter may play a role in alcohol relapse, addiction
April 19, 2018 - Researchers build molecular networks of calcific aortic valve disease
April 19, 2018 - Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens
April 19, 2018 - Scientists decipher mechanism of chemotherapy induced female infertility
April 19, 2018 - New insight may allow researchers to design drugs that improve immune responses to vaccines
April 19, 2018 - FDA Approves Crysvita (burosumab-twza) for X-Linked Hypophosphatemia
April 19, 2018 - Researchers uncover origin of virus-fighting plasma B cells
April 19, 2018 - Study finds no evidence of lower intelligence in young children who had anesthesia
April 19, 2018 - Baboons break out of research facility briefly
April 19, 2018 - Study shows how deployment time increases risk of suicide attempt in soldiers
April 19, 2018 - Specific odors from malaria infected individuals attract more mosquitoes
April 19, 2018 - FDA Alert: Rhino 69 Extreme 50000 by AMA Wholesale: Recall
April 19, 2018 - Top HIV cure research team refutes major recent results on how to identify HIV persistence
April 19, 2018 - Experts propose new solutions to increase benefit, affordability of targeted cancer medicines
April 19, 2018 - Deficiency of innate immune adaptor TRIF shortens survival time of ALS mice
April 19, 2018 - New machine learning method offers better way to detect heart disease
April 19, 2018 - CNIO researchers determine structure of protein complex related to cell survival
April 19, 2018 - Faith-based diabetes support program launched by UTSA research team
April 19, 2018 - Volumetric Laser Endomicroscopy Helps ID Barrett’s Regions
April 19, 2018 - Engineered cartilage template to heal broken bones
April 19, 2018 - New computational framework accurately predicts drug-drug and drug-food interactions
April 18, 2018 - Some human cancers may be result of evolutionary accidents, research finds
April 18, 2018 - Higher levels of education linked to lower dementia risk in older African Americans
April 18, 2018 - Smoking Puts Blacks at Higher Risk for Heart Failure
April 18, 2018 - Physiotherapist contributes to guidelines for knee cartilage treatment
April 18, 2018 - Researchers use ‘top-down proteomics’ strategy to get new insights into cancer
April 18, 2018 - Physician assistants less likely to accurately diagnose early stage skin cancers
April 18, 2018 - New faster, streamlined method for bowel cancer detection and treatment
April 18, 2018 - Researchers identify new Listeria species in Costa Rica
April 18, 2018 - Novel interactive diagram shows many facets of mild traumatic brain injury
April 18, 2018 - Short sleep linked to obesity in children and adolescents
April 18, 2018 - When weight loss helps with sleep
April 18, 2018 - New mathematical model can predict efficiency of microbiome therapies
April 18, 2018 - People with high LDL cholesterol levels likely to get greater benefits from statins
April 18, 2018 - Listening to music enhances effect of anti-hypertensive drugs
April 18, 2018 - New method could help treat severe epilepsy in the future
April 18, 2018 - Study reveals increased risks for Alzheimer’s, suicide among youth in polluted cities
April 18, 2018 - Obese patients more likely to develop rapid and irregular heart rate
April 18, 2018 - Study may change global guidelines for managing children with uncomplicated fever
April 18, 2018 - Researchers find letter we’ve seen millions of times, yet can’t write
April 18, 2018 - Roswell Park researchers identify driver of cancer-promoting metabolic changes
April 18, 2018 - Study shows connection between early life stress, depression and sleep disturbances
April 18, 2018 - New tool developed to protect women from HIV infection
April 18, 2018 - Tradeshow Talks with HealthSapiens
April 18, 2018 - NYC mice carry deadly bacteria and viruses
April 18, 2018 - FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia
April 18, 2018 - Doctors curbing first-time prescriptions for opioids
April 18, 2018 - Scientists analyze nanostructure of chicken eggshells
April 18, 2018 - Study finds muscle complications among active young adults with Type 1 diabetes
April 18, 2018 - Young children should be priority for snail fever treatment
April 18, 2018 - One class of diabetes drug not associated with reduced risk of death
April 18, 2018 - Breakthrough microscope revolutionizes live cell imaging of stem cells
April 18, 2018 - Study on arthritis prevalence and trends reveals unexpected findings
April 18, 2018 - Low-Vision Rehab Improves Several Elements of Visual Function
April 18, 2018 - Babies who look like their father at birth are healthier one year later: study
April 18, 2018 - New drug for migraine in the pipeline
April 18, 2018 - Precancerous colon polyps in Lynch syndrome patients display immune activation
April 18, 2018 - Mouse study shows how tungsten accumulates in the bones
April 18, 2018 - Scientists provide insight into how gene associated with autoimmunity contributes to disease
April 18, 2018 - AHA: Rx for Sedentary Kids — Friends and the Great Outdoors
April 18, 2018 - Expert panel reliable and accurate in identifying injuries in young children
April 18, 2018 - Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests
April 18, 2018 - New automated text messaging service may help combat opioid epidemic
April 18, 2018 - Large ALS-causing protein aggregates protect rather than harm neurons
April 18, 2018 - Older adults in high-quality nursing homes have lower risks for placement in long-term care facilities
April 18, 2018 - Targeting opioid receptor offers relief for chronic itching
April 18, 2018 - PBO long-lasting insecticidal nets found to be effective in reducing malaria prevalence
April 18, 2018 - New study maps links between 625 genes and different chemotherapy treatments
April 18, 2018 - Obesity rates keep rising for U.S. adults
April 18, 2018 - Bacterial ‘gene swapping’ affects emergence and spread of infectious diseases
April 18, 2018 - NSAIDs alone or with acetaminophen better than opioids at easing dental pain
Another Shocking Drug Price Hike

Another Shocking Drug Price Hike

image_pdfDownload PDFimage_print

The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data published in the Journal of Investigative Dermatology.

There was no association between market concentration and price of the oral antibiotic, wrote the study authors led by John S. Barbieri, MD, MBA, of the University of Pennsylvania Perelman School of Medicine, Philadelphia.

“This dramatic increase in the cost of doxycycline hyclate is not easily explained using the framework of a competitive market, suggesting non-competitive market forces may be responsible,” the authors wrote in their report.

There was also no change in prescribing behavior in response to the price increase, suggesting that “clinician or pharmacy level interventions could potentially increase utilization of less costly substitutes,” they added.

In their report, Barbieri and co-authors noted “recent inquiries” by the Department of Justice and others into companies involved in manufacturing doxycycline hyclate, suggest that “potentially anti-competitive behavior may be responsible for this dramatic price increase.”

Rising Costs

The retrospective analysis conducted by Barbieri and colleagues included de-identified U.S. medical and pharmacy claims data representing approximately 12-14 million annual covered lives.

The mean prescription cost for doxycycline hyclate increased from $7.16 in 2011 to $139.89 in 2013, amounting to an 1,854% increase, the analysis of claims data shows.

“This dramatic price increase was also associated with increased out-of-pocket expenditures for patients, increasing the financial burden of healthcare and potentially threatening access to care,” the authors said in their report.

The mean out-of-pocket cost for doxycycline hyclate increased 102% to $9.69, and the number of patients with total out-of-pocket expenses of at least $50 increased 50-fold, from 0.1% to 6.8%, their analysis shows.

In contrast, price increases of comparable magnitude were not seen for other oral tetracycline class antibiotics, the authors said. Over the same time period, the mean cost of prescriptions for doxycycline monohydrate and minocycline increased 8% and 2%, respectively, according to the analysis.

Market Findings

To evaluate how pricing changes affected the market share of the manufacturers of these antibiotics, the researchers calculated the Herfindahl-Hirschman index (HHI), a measure of market concentration that they said is commonly accepted and used by the Department of Justice to assess potential mergers.

The HHI is calculated by adding the squared market share percentage of each manufacturer in a market. The values of the HHI range from zero, when a market includes many firms with small market shares, to 10,000, when there is a single firm controlling the market, according to a description by the Department of Justice.

The markets for doxycycline hyclate, doxycycline monohydrate, and minocycline all had an HHI of at least 2,500 through the entire study period, which puts them in the “highly concentrated” market category, according to the report.

“This highly concentrated marketplace may provide a scenario prone to anti-competitive behavior given the relative lack of market participants,” Barbieri and colleagues wrote. “Alternatively, these highly concentrated markets may be at a tipping point between functioning as a competitive marketplace and a monopoly.”

The researchers also said they did not identify a significant association between the cost of doxycycline hyclate cost and HHI over the study period (β=0.030, 95% CI, -0.019-0.079, P=0.213).

That finding suggests the markets “do not appear to be functioning effectively as competitive markets for generic medications,” researchers said, though they added that the markets might behave in a “non-linear fashion that we are unable to model effectively in our analysis.”

Prescribing Patterns

Despite the price increases, providers did not shift prescribing behavior to less costly therapeutic alternatives, a finding that was “not surprising … given that price information is not transparent to patients or clinicians,” Barbieri and co-authors wrote.

Doxycycline hyclate prescriptions decreased by 1.9% from 2011 to 2013, according to the claims data analysis.

Over that same time period, doxycycline monohydrate prescriptions increased 2.5%, while extended-release doxycycline formulations increased by 0.1%, according to the report. Minocycline prescriptions increased 3.9%, and extended-release minocycline formulations decreased by 4.6%.

Clinicians could have saved $105.13 per prescription in 2013 by shifting from doxycycline hyclate to the least expensive oral tetracycline-class antibiotic, according to the authors’ calculations. In turn, patient out-of-pocket costs would have gone down by $5.77 for each prescription.

In total, that would have saved $10.7 million for the entire population in the claims database that year, and would have saved $761,000 in patient out-of-pocket costs, they added.

Since the claims data only represents a fraction of the United States population, the financial impact of choosing the least costly oral tetracycline-class antibiotic instead of doxycycline hyclate could be even more substantial, they added.

Beliefs that doxycycline hyclate is more efficacious or better tolerated than other oral tetracycline-class antibiotics may have made clinicians “reluctant” to change prescribing behavior, the authors suggested.

However, there is “limited evidence to support any particular oral antibiotic as being superior in the treatment of acne,” they said in their report.

This article originally appeared on our partner’s website Dermatology Times, which is a part of UBM Medica. (Free registration is required.)

2017-12-30T10:00:00-0500

Tagged with:

About author

Related Articles